IONS(Ionis Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $810.46M | $587.37M | $787.65M | $705.14M | $943.71M |
| 毛利润 | $799.61M | $573.25M | $778.51M | $693.92M | $927.80M |
| 营业利润 | −$30.19M | −$410.19M | −$353.73M | −$475.08M | −$381.68M |
| 净利润 | −$28.60M | −$269.72M | −$366.29M | −$453.90M | −$381.39M |
| 经营现金流 | $30.80M | −$274.37M | −$307.51M | −$500.95M | −$268.58M |
| 自由现金流 | $18.84M | −$290.09M | −$331.32M | −$546.23M | −$320.03M |
| 摊薄每股收益 | $-0.20 | $-1.90 | $-2.56 | $-3.04 | $-2.38 |